Stock Events

Stock Events

Bachem 

M$1,741.42
59
+M$0.00+0% Wednesday 15:34

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
0
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
0.59%
Dividend
10.22

Upcoming

Dividends

0.59%Dividend Yield
May 26
M$10.22
May 25
M$10.22
Apr 24
M$7.50
Apr 23
M$7.65
May 22
M$36.62
10Y Growth
-2.83%
5Y Growth
-23.3%
3Y Growth
-34.64%
1Y Growth
36.35%

Earnings

12MarExpected
Q2 2024
Q4 2024
Q2 2025
Q4 2025
8
14.31
20.62
26.93
Expected EPS
18.975157135199996
Actual EPS
N/A

Financials

20.09%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
13.29BRevenue
2.67BNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap236.38B
Amgen is a biotechnology company that competes with Bachem in the development and manufacturing of peptide-based therapeutics.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly is a pharmaceutical company with a strong focus on peptide and protein-based drugs, directly competing with Bachem's peptide synthesis services.
Novo Nordisk
NVO
Mkt Cap205.97B
Novo Nordisk specializes in diabetes care and biopharmaceuticals, including peptide treatments, making it a competitor in the peptide therapeutic market.
Pfizer
PFE
Mkt Cap162.16B
Pfizer is a global pharmaceutical corporation that competes with Bachem in the development and production of peptide and protein-based drugs.
Merck
MRK
Mkt Cap370.89B
Merck is a healthcare company that develops peptide-based therapeutics, competing with Bachem in the biopharmaceutical sector.
Sanofi
SNY
Mkt Cap106.01B
Sanofi is a global pharmaceutical company that develops peptide-based drugs, competing with Bachem in the peptide therapeutics market.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a biopharmaceutical company that competes with Bachem in the development of peptide and protein-based therapeutics.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol Myers Squibb is a global biopharmaceutical company that develops peptide and protein-based drugs, competing with Bachem.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.37B
Teva Pharmaceutical Industries is a global company that manufactures generic and specialty medicines, including peptide-based therapies, competing with Bachem in the generics and specialty drug market.

About

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.
Show more...
CEO
ISIN
CH1176493729

Listings

SW
CH
BANB.SW
STU
DE
BHM0.STU
MU
DE
BHM0.MU
OTC Link
US
BCHMY

0 Comments

Share your thoughts

FAQ

What is Bachem stock price today?▼
The current price of BANBN.MX is M$1,741.42 MXN — it has increased by +0% in the past 24 hours. Watch Bachem stock price performance more closely on the chart.
What is Bachem stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Mexican Exchange exchange Bachem stocks are traded under the ticker BANBN.MX.
What is Bachem revenue for the last year?▼
Bachem revenue for the last year amounts to 13.29B MXN.
What is Bachem net income for the last year?▼
BANBN.MX net income for the last year is 2.67B MXN.
Does Bachem pay dividends?▼
Yes, BANBN.MX dividends are paid annual. The last dividend per share was 10.22 MXN. As of today, Dividend Yield (FWD)% is 0.59%.
In which sector is Bachem located?▼
Bachem operates in the Other sector.
When did Bachem complete a stock split?▼
Bachem has not had any recent stock splits.